Advanced Pharma — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Advanced Pharma is a private, revenue-generating clinical research organization (CRO) founded in 1992. It provides specialized clinical trial services, leveraging its facility and database to recruit from healthy volunteer and special populations for early-phase (Phase 1) studies. The company operates in the drug delivery and broader biopharmaceutical services sector, supporting sponsor companies in navigating the complex clinical development pathway. Its established history suggests a focus on operational execution within the clinical research niche.

Drug Delivery

Technology Platform

A dedicated clinical research facility integrated with a proprietary database for recruiting healthy volunteers and special populations for early-phase clinical trials.

Opportunities

The growing volume of novel therapeutics entering human testing drives demand for specialized Phase 1 CRO services.

Its expertise in recruiting from special populations addresses a major industry bottleneck and is increasingly valuable for personalized medicine approaches.

Potential exists to expand service offerings or form strategic partnerships with emerging biotech companies.

Risk Factors

Heavy reliance on biopharma R&D spending cycles makes it vulnerable to industry downturns.

Intense competition from large global CROs creates pricing pressure and challenges in client acquisition.

Operational risks, such as patient recruitment delays or regulatory compliance issues, could damage reputation and financial stability.

Competitive Landscape

Advanced Pharma competes in the fragmented and highly competitive Clinical Research Organization (CRO) market. It faces competition from large, full-service global CROs (e.g., IQVIA, LabCorp, Parexel) as well as numerous smaller, niche CROs specializing in early-phase research. Differentiation is primarily based on therapeutic expertise, recruitment capabilities, operational efficiency, and cost.

More companies in Diagnostics & Precision Medicine →More companies in United States →